SI Stock Forecast & Price Target

Shoulder Innovations Inc. has demonstrated significant growth, ending FY25 with a striking 58% increase in total revenue to $11.8 million, surpassing estimates by $1.8 million. The company is experiencing accelerated customer growth, with a projected addition of 12 to 15 new surgeons each quarter, and a remarkable 61.4% year-over-year increase in Core-Contender surgeon customers. Management has raised its 2025 sales outlook to a range of $45 million to $46 million, indicating strong confidence in sustainable average selling prices and increasing product adoption among surgeons.

Shoulder Innovations Inc. reported an adjusted EBITDA loss of $7.5 million, exceeding prior models by approximately $400,000, highlighting a challenging financial landscape. Factors contributing to a negative outlook include sluggish adoption of its products by new surgeons, anticipated slower growth in the shoulder market, and an increase in operating expenses, which were approximately $900,000 higher than previously projected. Additionally, the company faced an overall EBITDA loss of $23.6 million, reflecting ongoing financial pressures and uncertainties surrounding market entry and pricing dynamics.